Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment.
CONCLUSIONS: Monitoring levels of EGFR mutation in plasma allows resolving doubts that frequently arise in daily clinical practice and constitutes a major step towards achieving personalized medicine.
PMID: 28947971 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Cancer | Cancer & Oncology | Lung Cancer | Men | Non-Small Cell Lung Cancer | Radiology | Study